Organon & Co

Financials

Overview Estratto Conto Statistics Dividends

Cash from operating activities 2.46 B858 M799 M939 M700 M 700 M Cash from investing activities 481 M420 M260 M513 M390 M 390 M Cash from financing activities 1.33 B433 M569 M368 M561 M 561 M Free cash flow 2.07 B538 M546 M659 M414 M 414 M

Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.

OGN

Financials

Organon & Co

Notizie

Organon presenta dati sul miglioramento del sonno con la crema VTAMA nei bambini

Organon presents sleep improvement data for VTAMA cream in children

Organon ottiene licenza per IUD al rame senza ormoni da Sebela Pharmaceuticals

Organon licenses hormone-free copper IUD from Sebela Pharmaceuticals

Organon Stock: Revenue Decline, Margin Pressure And Strategic Uncertainty (NYSE:OGN)

Il comitato di audit di Organon & Co. completa la revisione sui tempi di acquisto dei biosimilari

Le azioni Organon balzano del 6% dopo che l’audit non rileva irregolarità

Organon shares jump 6% after audit finds no misconduct

IXJ ETF: Healthcare Sector Dashboard For February (NYSEARCA:IXJ)

Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Organon (OGN) Misses Q4 Earnings and Revenue Estimates

Le azioni Organon calano oltre il 5% con utili del Q4 sotto le attese